Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
POSTER
The SmartCube Platform: Use of Phenotypic Screening in Mice with Machine Learning to Identify Novel Antipsychotic Compounds
POSTER
Elucidating Pain-Related Activity in the Eeg From the Rat Spinal Nerve Ligation Model (SNL) Of Neuropathic Pain
POSTER
Evaluation of Behavioral Pain Phenotype in the Rat Monoiodoacetateand Medial Meniscal Tear Models of Osteoarthritis Pain
POSTER
Evaluation of Behavioral Pain Phenotype and Optimization of the Rat Paclitaxel and Oxaliplatin Models of Chemotherapy-Induced Peripheral Neuropathy
POSTER
In Vivo PK, Side Effect Profile, and Efficacy of Multiple Classes of Analgesics in Rats
POSTER
Evaluation of the Abuse Liability of Oxycodone in Male and Female Rats Using Two Approaches: Intravenous Self-Administration and Conditioned Place Preference
POSTER
Characterization of a Model of Parkinson’s Disease Using Synthetic α-Synuclein Inoculation to Evaluate Motor Function, Synucleinopathy, and Dopaminergic Neurotransmission.
POSTER
The NIH HEAL Initiative Preclinical Screening Platform for Pain (PSPP) efforts to validate rodent models of pain and migraine
POSTER
